Establishment of the Intestinal Flora Transplantation Clinical Research Foundation
On Sunday, November 19, 2017, the Intestinal Flora Transplant Clinical Research Foundation was established.
The purpose of this research group, led by clinicians, is to establish a new treatment called “intestinal flora transplantation (fecal microorganism transplantation)” and to conduct activities to contribute to people’s health through research and development and clinical studies of intestinal flora transplantation.
The establishment ceremony was held at the “New Osaka Hotel” in Shin-Osaka. After the general meeting by the founding members, a study session and a reception were held, and despite being the first time, 30 people from all over Japan attended. We would like to take this opportunity to express our sincere appreciation.
Our study group will conduct activities to contribute to people’s health through research and development of intestinal flora transplantation and clinical studies.
The research and development department is located in the “Laboratory of Intestinal Bacteria (Symbiosis LLC)will be carrying out research and development. (The clinic has been conducting medical treatment and research as “Makoto Clinic,” but the research institute will be set up as an independent organization in conjunction with the launch of the research group.)
In the Clinical Research Division, specialists (“specialists”) will be appointed for each case, such as ulcerative colitis, Crohn’s disease, diabetes mellitus type II, psychiatric diseases, and immunological diseases. Partner Medical InstitutionsThe clinical research will be carried out by the “Japan Clinical Research Institute” (JCI).
Part 1: General Meeting
As the first part of the meeting, a general meeting was held by the founding members (directors, trustees, auditors, and the secretariat).
Part 2: Study Session (Panel Discussion)
Dr. Masayuki Asoholm (Life Clinic Tateshina: Nagano, Japan) started the study session.
Dr. Noriaki Man (Yorozu Clinic: Tottori, Japan)
Dr. Masahiko Shirotani (Luke’s Ashiya Clinic: Hyogo, Japan)
Mr. Makoto Shimizu (Symbiosis LLC)
Dr. Zen Tanaka (Tanaka Clinic: Osaka, Japan)
Everyone listened attentively.
Part 3: Social gathering
Toast by Mr. Goro Tsukamoto, Auditor.
Cheers! Congratulations!
We received a piece with a beaming smile. We have high expectations for the future of the study group.
The entire meeting was conducted in a friendly atmosphere.
The Intestinal Flora Transplantation Clinical Study Group will continue to devote itself to the work we have pledged to you at this founding meeting. We look forward to your continued support. その他の Notices and Activity Reports に関する記事
Articles about other Notices and Activity Reports

October 22, 2024
第7回学術大会【開催報告】
2024年9月22(日)に「第8回学術大会」を開催いたしました。会場とオンラインの同時開催で行い、医療関係者や一般企業の方、研究機関の方、患者様やご家族、そして一般の方など沢山の方々にご参加いただきました。皆様のお陰で無 […]

August 26, 2024
FMT on “Cancer” will be presented in the morning session.
Fecal Microflora Transplantation (FMT) on “Cancer” will be presented in the morning session of the 8th Annual Conference of The Association for Clinical Research of Fecal Microbiota Transplantation Japan to be held on Sunday, September 22, 2024. You can participate either at the venue (Rihga Royal Hotel Osaka) or online. The following is the program […]

August 23, 2024
The conference was introduced on the website of the Japan Society of Preemptive and Clinical Medicine.
We are pleased to announce that our “8th Annual Conference” has been introduced on the website of the Japan Society of Preemptive and Clinical Medicine Inc. We are also pleased to announce that we will be sponsoring the conference and will have a booth on the day of the conference. ・ ・ ・ Dr. Masahiko Shirotani, the […]